4//SEC Filing
Greenberg Richard S 4
Accession 0001214659-20-007221
CIK 0001625288other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:33 PM ET
Size
7.2 KB
Accession
0001214659-20-007221
Insider Transaction Report
Form 4
Greenberg Richard S
DirectorEVP and Chairman10% Owner
Transactions
- Conversion
Common Stock
2020-08-12$0.01/sh+1,800,880$25,212→ 2,688,880 total
Holdings
- 100,000
Options to purchase common stock (right to buy)
Exercise: $0.66From: 2018-10-26Exp: 2025-10-26→ Common Stock (100,000 underlying) - 150,000
Options to purchase common stock (right to buy)
Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ Common Stock (150,000 underlying)
Documents
Issuer
NEXIEN BIOPHARMA, INC.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001719461
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 5:33 PM ET
- Size
- 7.2 KB